Market Entry Facility RX83

Features

• Bulk bacterial vaccines production facility  
• Two production suites with centralised services  
• Biosafety containment level BL3 for live areas
• Flexible processing areas allowing rapid equipment changeover
• Campaign production for different products
• GMP compliance with EU and US FDA requirements
• Clean room classifications to EU grades B, C and D
• Integrated with off-plot Energy Centre for building utilities supply 
• Utilities floor incorporating kill tanks, clean utilities and building services 
• Future expansion building bay incorporated for scaled up process 
• Mezzanine level for HVAC systems above production level  
• Plant wide SCADA and materials tracking systems